iRadimed Corporation

37.39-1.22-3.16%Vol 82.33K1Y Perf 63.00%
Jan 21st, 2022 16:00 DELAYED
BID37.39 ASK37.47
Open38.17 Previous Close38.61
Pre-Market- After-Market36.00
 - -  -1.39 -3.72%
Target Price
42.00 
Analyst Rating
Strong Buy 1.00
Potential %
12.33 
Finscreener Ranking
★★★+     51.04
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★     52.11
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★+     64.51
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
53.85 
Earnings Rating
Strong Buy
Market Cap461.47M 
Earnings Date
4th Feb 2022
Alpha0.02 Standard Deviation0.13
Beta0.84 

Today's Price Range

37.0439.02

52W Range

21.6550.88

5 Year PE Ratio Range

12.90969.40

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-15.10%
1 Month
-17.88%
3 Months
1.49%
6 Months
7.57%
1 Year
63.00%
3 Years
58.10%
5 Years
306.41%
10 Years
-

TickerPriceChg.Chg.%
IRMD37.39-1.2200-3.16
AAPL162.41-2.1000-1.28
GOOG2 601.84-68.2900-2.56
MSFT296.03-5.5700-1.85
XOM72.17-1.1000-1.50
WFC53.67-1.3300-2.42
JNJ164.87-0.3800-0.23
FB303.17-13.3900-4.23
GE96.30-1.9500-1.98
JPM145.08-2.5800-1.75
Earnings HistoryEstimateReportedSurprise %
Q03 20210.150.2033.33
Q02 20210.120.120.00
Q01 20210.060.1183.33
Q04 20200.060.05-16.67
Q03 20200.020.09350.00
Q02 2020-0.07-0.17-142.86
Q01 20200.090.1455.56
Q04 20190.180.2644.44
Earnings Per EndEstimateRevision %Trend
12/2021 QR0.1820.00Positive
12/2021 QR0.150.00-
12/2021 FY0.6216.98Positive
12/2022 FY0.744.23Positive
Next Report Date4th Feb 2022
Estimated EPS Next Report0.18
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume82.33K
Shares Outstanding12.34M
Shares Float6.53M
Trades Count1.62K
Dollar Volume3.30M
Avg. Volume71.93K
Avg. Weekly Volume71.35K
Avg. Monthly Volume65.80K
Avg. Quarterly Volume68.74K

iRadimed Corporation (NASDAQ: IRMD) stock closed at 37.39 per share at the end of the most recent trading day (a -3.16% change compared to the prior day closing price) with a volume of 82.63K shares and market capitalization of 461.47M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 114 people. iRadimed Corporation CEO is Roger Susi.

The one-year performance of iRadimed Corporation stock is 63%, while year-to-date (YTD) performance is -19.09%. IRMD stock has a five-year performance of 306.41%. Its 52-week range is between 21.65 and 50.88, which gives IRMD stock a 52-week price range ratio of 53.85%

iRadimed Corporation currently has a PE ratio of 91.80, a price-to-book (PB) ratio of 8.01, a price-to-sale (PS) ratio of 18.15, a price to cashflow ratio of 53.20, a PEG ratio of 2.32, a ROA of 8.21%, a ROC of 9.06% and a ROE of 9.50%. The company’s profit margin is 18.14%, its EBITDA margin is 22.70%, and its revenue ttm is $29.94 Million , which makes it $2.43 revenue per share.

Of the last four earnings reports from iRadimed Corporation, there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.18 for the next earnings report. iRadimed Corporation’s next earnings report date is 04th Feb 2022.

The consensus rating of Wall Street analysts for iRadimed Corporation is Strong Buy (1), with a target price of $42, which is +12.33% compared to the current price. The earnings rating for iRadimed Corporation stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

iRadimed Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

iRadimed Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 11.88, ATR14 : 2.28, CCI20 : -206.82, Chaikin Money Flow : -0.25, MACD : -1.28, Money Flow Index : 23.10, ROC : -24.50, RSI : 30.00, STOCH (14,3) : 2.53, STOCH RSI : 0.00, UO : 28.92, Williams %R : -97.47), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of iRadimed Corporation in the last 12-months were: Anthony F. Vuoto (Option Excercise at a value of $0), Anthony F. Vuoto (Sold 3 690 shares of value $137 381 ), Chris Scott (Option Excercise at a value of $0), Chris Scott (Sold 70 000 shares of value $2 852 623 ), James B. Hawkins (Option Excercise at a value of $0), James B. Hawkins (Sold 148 059 shares of value $6 114 656 ), Monty Allen (Option Excercise at a value of $35 500), Monty Allen (Sold 4 597 shares of value $156 666 ), Roger Susi (Sold 210 000 shares of value $7 960 297 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

iRadimed Corporation

iRadimed Corp is a US-based company that mainly develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold primarily to hospitals and acute care facilities in the United States and internationally.

CEO: Roger Susi

Telephone: +1 407 677-8022

Address: 1025 Willa Springs Drive, Winter Springs 32708, FL, US

Number of employees: 114

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

63%38%

Bearish Bullish

63%37%

News

Stocktwits